X连锁视网膜病变:生理机制、致病机理、表型特征与新型治疗
本文综述了X连锁视网膜病变的生理基础、致病机制、临床表型及新兴疗法,涵盖RPGR、RP2、CHM、RS1等基因相关疾病,并探讨了X染色体失活、携带者表型及基因治疗策略。文章还基于临床遗传队列分析了X连锁基因的疾病负担,并提出了非综合征性X连锁视网膜病变的诊断基因考量流程。
要点
- X连锁视网膜病变包括进展性和静止性、综合征和非综合征类型,女性携带者也可表现表型。
- 同一基因变异可导致多样表型,如RPGR相关视网膜病变,且当前测序方法存在局限。
- X连锁疾病多由功能丧失引起,基因替代治疗可能获益,多种实验性疗法正在探索。
核心结论
- X连锁视网膜病变是单基因视网膜病的重要组成部分,基因治疗策略具有潜力。
- 女性携带者表型有助于诊断和机制研究,但可能误导为常染色体显性遗传。
研究设计与样本
- 综述性文章,结合临床遗传队列分析X连锁基因的疾病负担。
- 使用近期转录组分析探索细胞类型表达,并讨论电生理学见解。
主要发现
- X连锁基因转录本长度与家族数量相关。
- RPGR相关视网膜病变表型多样,同一基因变异可导致不同临床表型。
- 女性携带者表型可帮助建立诊断并揭示疾病机制。
关键数值与推荐
- 列举了RPGR、RP2、CHM、RS1、NYX、CACNA1F、OPN1LW/OPN1MW、GPR143、COL4A5、NDP等基因及相关疾病。
- 提出了诊断男性非综合征性X连锁视网膜病变的基因考量算法。
临床怎么用
- 临床诊断中应考虑X连锁遗传模式,注意女性携带者表型。
- 基因检测时需注意测序方法的局限性,结合临床表型综合判断。
- 基因替代治疗可能对功能丧失导致的X连锁疾病有益。
局限性
- 当前遗传测序方法存在局限性;综述未报告具体研究样本量或统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
X-linked retinopathies represent a significant proportion of monogenic retinal disease. They include progressive and stationary conditions, with and without syndromic features. Many are X-linked recessive, but several exhibit a phenotype in female carriers, which can help establish diagnosis and yield insights into disease mechanisms. The presence of affected carriers can misleadingly suggest autosomal dominant inheritance. Some disorders (such as RPGR-associated retinopathy) show diverse phenotypes from variants in the same gene and also highlight limitations of current genetic sequencing methods. X-linked disease frequently arises from loss of function, implying potential for benefit from gene replacement strategies. We review X-inactivation and X-linked inheritance, and explore burden of disease attributable to X-linked genes in our clinically and genetically characterised retinal disease cohort, finding correlation between gene transcript length and numbers of families. We list relevant genes and discuss key clinical features, disease mechanisms, carrier phenotypes and novel experimental therapies. We consider in detail the following: RPGR (associated with retinitis pigmentosa, cone and cone-rod dystrophy), RP2 (retinitis pigmentosa), CHM (choroideremia), RS1 (X-linked retinoschisis), NYX (complete congenital stationary night blindness (CSNB)), CACNA1F (incomplete CSNB), OPN1LW/OPN1MW (blue cone monochromacy, Bornholm eye disease, cone dystrophy), GPR143 (ocular albinism), COL4A5 (Alport syndrome), and NDP (Norrie disease and X-linked familial exudative vitreoretinopathy (FEVR)). We use a recently published transcriptome analysis to explore expression by cell-type and discuss insights from electrophysiology. In the final section, we present an algorithm for genes to consider in diagnosing males with non-syndromic X-linked retinopathy, summarise current experimental therapeutic approaches, and consider questions for future research.
引用
- De Silva SR, Arno G, Robson AG, et al. The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res. 2020. PMID: 32860923. doi:10.1016/j.preteyeres.2020.100898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。